©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Sep 24, 2020; 11(9): 723-731
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.723
Published online Sep 24, 2020. doi: 10.5306/wjco.v11.i9.723
Circulating tumor DNA: Where are we now? A mini review of the literature
Gliceida Maria Galarza Fortuna, Kathrin Dvir, Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, United States
Author contributions: Galarza Fortuna GM and Dvir K were in charge of conceptualization, data curation, methodology, project administration, and writing the original draft and the definite version of the manuscript.
Conflict-of-interest statement: Galarza Fortuna GM and Dvir K have no conflict of interest to disclose.
Corresponding author: Gliceida Maria Galarza Fortuna, MD, Internal Medicine, Mount Sinai Medical Center, 4300 Alton Road, Miami Beach, FL 33140, United States. gliceida.galarza@gmail.com
Received: April 29, 2020
Peer-review started: April 29, 2020
First decision: July 25, 2020
Revised: July 31, 2020
Accepted: September 2, 2020
Article in press: September 2, 2020
Published online: September 24, 2020
Processing time: 142 Days and 12.1 Hours
Peer-review started: April 29, 2020
First decision: July 25, 2020
Revised: July 31, 2020
Accepted: September 2, 2020
Article in press: September 2, 2020
Published online: September 24, 2020
Processing time: 142 Days and 12.1 Hours
Core Tip
Core Tip: This report provides an updated review of the clinical utilities of liquid biopsy for the screening, diagnosis, prognosis and treatment of cancer.